Pharma Lab CRO ApS: Financial statements 2022
CVR: 40729364
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Pharma Lab CRO ApS (CVR 40729364) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,648,274 and a net result of DKK 42,586 compared with DKK 1,762,562 the year before. That is a decrease of 30.9% compared with the year before. Equity in the 2022 report amounted to DKK 2,255,573. The solvency ratio was 13.2%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,648,274
- Profit/Loss
- DKK 42,586
- Equity
- DKK 2,255,573
- Total Assets
- DKK 17,151,820
- Employees
- 2
Official annual report
Keep an eye on Pharma Lab CRO ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Pharma Lab CRO ApS has published its annual report for 2021. Gross profit came to DKK 2,384,084, and the net result was DKK 1,762,562.
About Pharma Lab CRO ApS
Pharma Lab CRO ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jakob Juul Rasmussen. The company is owned by JaJR Holding 2 ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,665,168 and a net result of DKK -299,305 compared with DKK 117,249 the year before. Equity in the 2025 report amounted to DKK -5,311,766.